Charles River Laboratories CRL Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Charles River Laboratories's share buybacks?
- Charles River Laboratories (CRL) reported share buybacks of $208.29M in Q1 2026.
- How has Charles River Laboratories's share buybacks changed year-over-year?
- Charles River Laboratories's share buybacks decreased by 41.0% year-over-year, from $353.13M to $208.29M.
- What is the long-term trend for Charles River Laboratories's share buybacks?
- Over 4 years (2021 to 2025), Charles River Laboratories's share buybacks has grown at a 72.5% compound annual growth rate (CAGR), from $40.71M to $360.67M.
- What does share buybacks mean?
- Cash spent by the company to buy back its own stock.
- How do you interpret share buybacks?
- Higher values indicate a return of capital to shareholders and confidence in the stock price, while lower values suggest capital preservation or reinvestment.
- How does share buybacks compare across companies?
- Standard practice for mature, cash-generative companies in the sector.